 | Up a level |
Boyer-Diaz, Zoe; Aristu-Zabalza, Peio; Andrés-Rozas, María; Robert, Claude; Ortega-Ribera, Martí; Fernández-Iglesias, Anabel; Broqua, Pierre; Junien, Jean-Louis; Wettstein, Guillaume; Bosch, Jaime; Gracia-Sancho, Jordi (2021). Pan-PPAR agonist lanifibranor improves portal hypertension and hepatic fibrosis in experimental advanced chronic liver disease. Journal of hepatology, 74(5), pp. 1188-1199. Elsevier 10.1016/j.jhep.2020.11.045
Boyer-Diaz, Zoe; Morata, Paloma; Aristu-Zabalza, Peio; Gibert-Ramos, Albert; Bosch, Jaime; Gracia-Sancho, Jordi (2020). Oxidative Stress in Chronic Liver Disease and Portal Hypertension: Potential of DHA as Nutraceutical. Nutrients, 12(9) Molecular Diversity Preservation International MDPI 10.3390/nu12092627
Boyer-Diaz, Zoe; Domingo, Joan Carles; De Gregorio, Estefanía; Manicardi, Nicolò; Aristu-Zabalza, Peio; Cordobilla, Begoña; Abad-Jordà, Laia; Ortega-Ribera, Martí; Fernández-Iglesias, Anabel; Marí, Montserrat; Bosch, Jaime; Gracia-Sancho, Jordi (2019). A Nutraceutical Rich in Docosahexaenoic Acid Improves Portal Hypertension in a Preclinical Model of Advanced Chronic Liver Disease. Nutrients, 11(10) Molecular Diversity Preservation International MDPI 10.3390/nu11102358
